Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 |
filingDate |
2011-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_038c31778ded2f16e915562d3c4eafbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b10275e48092fa51fb161f5adebd5d2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fcbbb0da9468130ccfa2cf4dde3e6b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_920f5eeedc040e0b14bb7946dbfeb411 |
publicationDate |
2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-103298470-B |
titleOfInvention |
Use of magnesium stearate in dry powder formulations for inhalation |
abstract |
The invention relates to the use of magnesium stearate in powder formulation for inhalation comprising carrier particles to inhibit or reduce chemical degradation of an active ingredient bearing a group susceptible to hydrolysis. A pharmaceutical formulation in form of dry powder for inhalation comprising (a) a carrier, (b) magnesium stearate, and c) an active ingredient substance susceptible to hydrolysis is also provided. |
priorityDate |
2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |